Cargando…
Managing clinical trials
Managing clinical trials, of whatever size and complexity, requires efficient trial management. Trials fail because tried and tested systems handed down through apprenticeships have not been documented, evaluated or published to guide new trialists starting out in this important field. For the past...
Autores principales: | Farrell, Barbara, Kenyon, Sara, Shakur, Haleema |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2917433/ https://www.ncbi.nlm.nih.gov/pubmed/20626885 http://dx.doi.org/10.1186/1745-6215-11-78 |
Ejemplares similares
-
Response to: The BRAIN TRIAL: a randomized, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury - authors' reply
por: Roberts, Ian, et al.
Publicado: (2009) -
Accuracy of time to treatment estimates in the CRASH-3 clinical trial: impact on the trial results
por: Mansukhani, Raoul, et al.
Publicado: (2020) -
Using a business model approach and marketing techniques for recruitment to clinical trials
por: McDonald, Alison M, et al.
Publicado: (2011) -
A nested mechanistic sub-study into the effect of tranexamic acid versus placebo on intracranial haemorrhage and cerebral ischaemia in isolated traumatic brain injury: study protocol for a randomised controlled trial (CRASH-3 Trial Intracranial Bleeding Mechanistic Sub-Study [CRASH-3 IBMS])
por: Mahmood, Abda, et al.
Publicado: (2017) -
A nested randomised trial of the effect of tranexamic acid on intracranial haemorrhage and infarction in traumatic brain injury (CRASH-3 trial intracranial bleeding mechanistic study): Statistical analysis plan
por: Mahmood, Abda, et al.
Publicado: (2019)